Breast Cancer Research and Treatment

Index Medicus: Breast Cancer Res Treat # of Articles: 39

Articles

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer Mcf-7 cells
  Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K
  Yr:1997 Vol:42 Nbr: Pgs: 73-81
  Associated Grant: Bax gene expression in breast cancer
     
Intrinsic reactivity of tamozifen and Toremifene metabolites with DNA
  Hellmann-Blumber U, Carter MG, Wauz GT, and DeGregorio MW
  Yr:1998 Vol:50 Nbr:2 Pgs: 135-141
  Associated Grant: Studies of Tamoxifen/Toremifene DNA interactions in monkeys
     
Apoptosis - A cell mechanism important for cytotoxic response to adriamycin and a lipid metabolic pathway that facilitates escape
  Cabot MC, and Giuliano AE
  Yr:1997 Vol:46 Nbr:1 Pgs: 71
  Associated Grant: Nongenomic actions of antiestrogens
     
Espression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
  Zapata JM, Krajewska M, Krajewski S, Huang R-P, Takayama S, and Adamson E, et al
  Yr:1998 Vol:47 Nbr: Pgs: 129-140
  Associated Grant: TRAF-regulated Signal Transduction in Breast Cancer
     
Tamoxifen metabolite Bx causes DNA adducts
  Hellmann-Blumberg U, and DeGregorio MW
  Yr:1997 Vol:46 Nbr: Pgs: 85
  Associated Grant: Studies of Tamoxifen/Toremifene DNA interactions in monkeys
     
Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors
  Zapata JM, Krajewska M, Krajewski S, Huang R-P, Takayama S, and Reed JC, et al
  Yr:1998 Vol:47 Nbr: Pgs: 129-140
  Associated Grant: Immune responses to breast cancers: function of TRAF protein
     
Contortrstatin, a dimeric disintigrin from Agkistrodon contortrix contortrix, inhibits breast cancer angiogenesis.
  Zhou Q, Sherwin RP, Arnold C, Richters V, Groshen SG, Tsao-Wei D, and Markland FS
  Yr:2000 Vol:61 Nbr: Pgs: 249-260
  Associated Grant: Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer
     
Reproductive risk factors, family history, and breast cancer risk among postmenopausal women
  Carpenter CL, Ross RK, Paganini-Hill A, and Bernstein L.
  Yr:1999 Vol:57 Nbr: Pgs: 83
  Associated Grant: Physical Activity: Impact on Hormones and Breast Cancer Risk
     
Body size, lifetime physical activity, and breast cancer risk among postmenopausal women
  Carpenter CL, Ross RK, Paganini-Hill A, and Bernstein L.
  Yr:1996 Vol:41 Nbr: Pgs: 225
  Associated Grant: Physical Activity: Impact on Hormones and Breast Cancer Risk
     
Suppression of aromatase (estrogen synthetase) by red wine phytochemicals.
  ET Eng, D Williams, U Mandava, N Kirma, RR Tekmal, and S Chen.
  Yr:2001 Vol:67 Nbr:2 Pgs: 133-46
  Associated Grant: Breast Cancer Prevention with Phytoestrogens in Grape Juice
     
Homeobox genes in mammary glad development and neoplasia.
  MT Lewis
  Yr:2000 Vol:2 Nbr: Pgs: 158-169
  Associated Grant: Homeobox Genes: A New Class of Human Breast Oncogenes?
     
Contortrostatin, a Dimeric Disintegrin from Agkistrodon contortrix contortrix, Inhibits Breast Cancer Progression.
  Zhou Q, Sherwin RP, Arnold C, Richters V, Groshen SG, Tsao-Wei D, Markland FS
  Yr:2000 Vol:61 Nbr: Pgs: 249-260
  Associated Grant: Breast Cancer Gene Therapy Using a Metastasis Inhibitor
     
Effect of thermal variables on human breast cancer in cryosurgery.
  Rui J, Tatsutani KN, Dahiya R, Rubinsky B
  Yr:1999 Vol:53 Nbr:2 Pgs: 185-9
  Associated Grant: Pre-clinical cryosurgery testing in breast cancer treatment
     
Comprehensive screening using breast MRI and ductal lavage in high-risk women. San Antonio Breast Cancer Symposium.
  Hartman AR, Daniel BL, Ford JM, Chun NM, Kingham KE, et al
  Yr:2002 Vol:76S1 Nbr: Pgs: 618
  Associated Grant: Genetic Alterations in MRI Screen-Detected Breast Lesions
     
Characterization of breast composition uing magnetic resonance imaging and diffuse optical spectroscopy
  Klifa C, Shah J, Gibbs B, Tromberg B, and Hylton N
  Yr:2004 Vol:88 Nbr:1 Pgs: S163
  Associated Grant: MRI for High Risk Breast Cancer Screening and Surveillance
     
Bone mineral density and adjuvant therapy in breast cancer survivors.
  Crandall C, Petersen L, Ganz PA, Greendale GA.
  Yr:2005 Vol:88 Nbr:3 Pgs: 257-261
  Associated Grant: Impact of Breast Cancer and its Therapy on Bone Density
     
Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells
  Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J
  Yr:2005 Vol:94 Nbr:1 Pgs: 37-46
  Associated Grant: Potential New Drug Therapy for Breast Cancer
     
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
  Rugo, H., Shtivelman, E., Perez, A, et al.
  Yr:2007 Vol: Nbr: Pgs:
  Associated Grant: Herba Scutellaria Barbatae for Metastatic Breast Cancer
     
Essiac and Flor-Essence herbal tonics stimulate the in vitro growth of human breast cancer cells.
  Kulp, K., Montgomery, J., Nelson, D., et.al.
  Yr:2006 Vol:98 Nbr:3 Pgs: 249-59
  Associated Grant: Studying the Interaction of an Essiac Tea and Food Mutagen
     
Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
  Hodges-Gallagher L, Valentine CD, Bader SE, Kushner PJ
  Yr:2007 Vol:Epub Nbr: Pgs: PMID: 17638070
  Associated Grant: Estrogen Receptor Beta Agonists to Prevent Breast Cancer
     
Central carbon metabolism in the progression of mammary carcinoma.
  Richardson AD, Yang C, Osterman A, Smith JW.
  Yr:2008 Vol:110 Nbr:2 Pgs: 297-307
  Associated Grant: Modeling, Targeting Acetyl-CoA Metabolism in Breast Cancer
     
Papillary carcinoma of the breast: an overview.
  Pal SK, Lau SK, Kruper L, et al.
  Yr:2010 Vol:122 Nbr:3 Pgs: 637-45
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
     
Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
  Leslie Hodges-Gallagher, Cathleen D. Valentine, Suzy El Bader, Peter J. Kushner
  Yr:2008 Vol:109 Nbr: Pgs: 241-250
  Associated Grant: Protective Role of Estrogen Receptor Beta in Mammary
     
Inhbition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells
  Leslie Hodges-Gallagher, Cathleen D. Valentine, Suzy El Bader, Peter J. Kushner
  Yr:2007 Vol:105 Nbr: Pgs: 297-309
  Associated Grant: Protective Role of Estrogen Receptor Beta in Mammary
     
Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer.
  Liu Y, Diamant AL, Thind A, Maly RC
  Yr:2009 Vol: Nbr: Pgs: June 2009, ePub
  Associated Grant: Determinants of Breast Cancer Treatment in the Underserved
     
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
  Sharma M, Beck AH, et al and West RB
  Yr:2010 Vol:123 Nbr:2 Pgs: 397-404
  Associated Grant: Stroma Expression Patterns in Breast Cancer
     
Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting.
  Tam EK, Shen L, Munneke JR, and Kwan ML
  Yr:2011 Vol: Nbr: Pgs: Oct 29. [Epub)
  Associated Grant: Patient and Clinician Knowledge of Breast Cancer Lymphedema
     
Clinical and biomarker predictors of side effects from tamoxifen.
  Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E
  Yr:2012 Vol:132 Nbr:3 Pgs: 1107-18
  Associated Grant: Genetics of Tamoxifen Response
     
Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
  Mukhtar RA, Moore A, Nseyo O, Baehner F, Au A, Moore D, Twomey P, Campbell M, Esserman L
  Yr:2011 Vol:130 Nbr:2 Pgs: 635-44
  Associated Grant: Macrophages in Breast Cancer Patients of African Descent
     
Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.
  Wu AH, Lorizio W, Tchu S, Lynch K, Gerona R, Ji W, Ruan W, Ruddy KJ, et al, and Ziv E
  Yr:2012 Vol:133 Nbr:2 Pgs: 677-83
  Associated Grant: Genetics of Tamoxifen Response
     
Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1
  J. G. Dowty1, E. Lee2, R. McKean-Cowdin2, B. E. Henderson2, L. Bernstein3, G. Ursin2 et al
  Yr: Vol: Nbr: Pgs:
  Associated Grant: Oral Contraceptives, Hormonal Risk Factors and BRCA1
     
HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics.
  Fasching PA, Weihbrecht, S, Gasparyan A, et al.
  Yr:2014 Vol:145 Nbr:1 Pgs: 193-203
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
     
Expression profiling of circulating tumor cells in metastatic breast cancer.
  Lang JE, Scott JH, Wolf DM, Novak P Punj V et al.
  Yr:2015 Vol:149 Nbr:1 Pgs: 121-131
  Associated Grant: Expression Profiling of Circulating Tumor Cells
     
Determinants of participation in treatment decision-making by older breast cancer patients
  Maly, RC, Umezawa Y, Leake B, Silliman RA
  Yr:2004 Vol:85 Nbr:3 Pgs: 201-9
  Associated Grant: Determinants of Breast Cancer Treatment in the Underserved
     
Effective treatment of HER2-amplified breast cancer by targeting HER3 and 1 integrin doi:10.1007/s10549-016-3698-y
  M R. Campbell, H Zhang, S Ziaee, A. Ruiz-Saenz, N Gulizia, J Oeffinger, D N Amin, et al.
  Yr:2016 Vol:155 Nbr:3 Pgs: 431-40
  Associated Grant: Understanding HER3 and mTor Signaling in Breast Cancer
     
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin doi:10.1007/s10549-016-3698-y
  MR Campbell, H Zhang, S Ziaee, A Ruiz-Saenz, N Gulizia, J Oeffinger, DN Amin, et al.
  Yr:2016 Vol:155 Nbr:3 Pgs: 431-40
  Associated Grant: Towards Highly Effective Inactivation of HER2-HER3 Signaling
     
Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study DOI: 10.1007/s10549-016-3810-3
  AE Connor, K Visvanathan, KB Baumgartner, RN Baumgartner, SD Boone, LM Hines et a.
  Yr:2016 Vol:157 Nbr:1 Pgs: 167-78
  Associated Grant: Migration and Breast Cancer Risk in Hispanics
     
AroER tri-screenTM is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens
  Kanaya N., Nguyen D.M., Lu H., Wang Y-Z., Hsin L-Y., Petreas M., Nelson D., et al
  Yr:2015 Vol:151 Nbr: Pgs: 335-45
  Associated Grant: Biologically relevant screening of endocrine disruptors
     
Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study doi:10.1007/s10549-016-4048-9
  Connor, AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone S et al.
  Yr:2016 Vol: Nbr: Pgs:
  Associated Grant: Migration and Breast Cancer Risk in Hispanics